Lucid Diagnostics, Inc. (LUCD)
0.6029
+0.01
(+1.62%)
USD |
NASDAQ |
Oct 06, 16:00
0.6101
+0.01
(+1.19%)
After-Hours: 20:00
Lucid Diagnostics Cash from Operations (Quarterly) : -11.30M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.30M |
| March 31, 2026 | -12.10M |
| December 31, 2025 | -12.58M |
| September 30, 2025 | -10.89M |
| June 30, 2025 | -10.55M |
| March 31, 2025 | -12.46M |
| December 31, 2024 | -9.871M |
| September 30, 2024 | -10.18M |
| June 30, 2024 | -11.48M |
| March 31, 2024 | -12.61M |
| December 31, 2023 | -9.979M |
| September 30, 2023 | -8.781M |
| June 30, 2023 | -7.012M |
| Date | Value |
|---|---|
| March 31, 2023 | -7.045M |
| December 31, 2022 | -4.258M |
| September 30, 2022 | -6.346M |
| June 30, 2022 | -13.30M |
| March 31, 2022 | -5.776M |
| December 31, 2021 | -9.283M |
| September 30, 2021 | -2.629M |
| June 30, 2021 | -2.441M |
| March 31, 2021 | -3.315M |
| December 31, 2020 | -1.676M |
| September 30, 2020 | -1.555M |
| June 30, 2020 | -1.282M |
| March 31, 2020 | -1.116M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 347.16M |
| Neogen Corp. | 30.20M |
| QuidelOrtho Corp. | -110.60M |
| Aspira Women's Health, Inc. | -2.01M |
| VolitionRX Ltd. | -4.993M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.021M |
| Cash from Financing (Quarterly) | 16.85M |
| Free Cash Flow | -47.18M |
| Free Cash Flow Per Share (Quarterly) | -0.0618 |
| Free Cash Flow to Equity (Quarterly) | -9.424M |
| Free Cash Flow to Firm (Quarterly) | -11.31M |
| Free Cash Flow Yield | -55.65% |